Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Zydus Lifesciences Says FDA Accepts Sentynl's Cutx-101 NDA Resubmission

Dec 15 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS:

FDA ACCEPTS SENTYNL'S CUTX-101 NDA RESUBMISSION

NEW PDUFA DATE FOR CUTX-101 SET FOR JANUARY 14, 2026

Source text: ID:nBSE58TbJm

Further company coverage: ZYDU.NS

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zydus Lifesciences

See all news